Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
EMD Serono
Scientific Title
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+ Non-small Cell Lung Cancer